Haisco Pharmaceutical Group Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 623.64 million compared to CNY 562.01 million a year ago. Revenue was CNY 623.64 million compared to CNY 562.01 million a year ago.

Net income was CNY 28.75 million compared to CNY 26.2 million a year ago. Basic earnings per share from continuing operations was CNY 0.03 compared to CNY 0.02 a year ago. Diluted earnings per share from continuing operations was CNY 0.03 compared to CNY 0.02 a year ago.